Cardlytics Inc (CDLX)

Currency in USD
1.21
+0.01(+0.83%)
Closed·
1.18-0.03(-2.34%)
·
CDLX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.191.24
52 wk Range
0.854.03
Key Statistics
Prev. Close
1.2
Open
1.2
Day's Range
1.19-1.24
52 wk Range
0.85-4.03
Volume
326.97K
Average Volume (3m)
880.9K
1-Year Change
-68.8144%
Book Value / Share
-0.09
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CDLX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1.63
Upside
+34.30%
Members' Sentiments
Bearish
Bullish
ProTips
3 analysts have revised their earnings downwards for the upcoming period

Cardlytics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Buy

Cardlytics Inc Company Profile

Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. The company offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. Cardlytics, Inc. was incorporated in 2008 and is headquartered in Atlanta, Georgia.

Employees
367

Cardlytics Inc Earnings Call Summary for Q3/2025

  • Cardlytics (CDLX) reported Q3 2025 EPS of -$0.07, outperforming the expected -$0.33, while revenue fell 22.4% YoY to $52M, missing the $67.33M forecast.
  • Despite revenue challenges, the company achieved positive adjusted EBITDA of $3.2M and reduced operating expenses by $11.4M, demonstrating improved operational efficiency.
  • For Q4 2025, Cardlytics forecasts billings of $86-96M, revenue of $51.1-59.1M, and adjusted EBITDA between $0.9-7.9M.
  • CEO Amit Gupta outlined 2026 strategic priorities including expanding the Cardlytics Rewards Platform partner network and strengthening financial institution partnerships.
  • The stock rose 1.44% in aftermarket trading to $1.74, suggesting investor optimism about the narrower-than-expected loss despite revenue shortfalls.
Last Updated: 2025-11-05, 06:06 p/m
Read Full Transcript

Compare CDLX to Peers and Sector

Metrics to compare
CDLX
Peers
Sector
Relationship
P/E Ratio
−0.6x−1.3x6.0x
PEG Ratio
−0.010.010.01
Price/Book
−13.9x1.5x1.8x
Price / LTM Sales
0.3x1.2x1.5x
Upside (Analyst Target)
24.0%56.7%28.3%
Fair Value Upside
Unlock20.4%14.7%Unlock

Analyst Ratings

0 Buy
4 Hold
1 Sell
Ratings:
5 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 1.63
(+34.30% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Craig-Hallum
Hold1.50+23.97%2.00MaintainAug 07, 2025
Lake Street Capital Markets
Hold2.50+106.61%3.00MaintainJul 08, 2025
Craig-Hallum
Hold2.00+65.29%3.00MaintainMay 08, 2025
Lake Street Capital Markets
Hold2.50+106.61%3.00MaintainMay 08, 2025
Evercore ISI
Hold3.00+147.93%4.00MaintainMar 13, 2025

Earnings

Latest Release
Nov 05, 2025
EPS / Forecast
-0.07 / -0.33
Revenue / Forecast
52.00M / 67.33M
EPS Revisions
Last 90 days

CDLX Income Statement

People Also Watch

274.95
PRTP
-1.82%
0.527
MREO
-0.94%
6.99
DAVA
+2.19%
1.210
OPAD
-5.47%
10.900
GRLS
+0.09%

FAQ

What Is the Cardlytics (CDLX) Stock Price Today?

The Cardlytics stock price today is 1.21

What Stock Exchange Does Cardlytics Trade On?

Cardlytics is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Cardlytics?

The stock symbol for Cardlytics is "CDLX."

What Is the Cardlytics Market Cap?

As of today, Cardlytics market cap is 65.41M.

What Is Cardlytics's Earnings Per Share (TTM)?

The Cardlytics EPS (TTM) is -2.12.

When Is the Next Cardlytics Earnings Date?

Cardlytics will release its next earnings report on Mar 03, 2026.

From a Technical Analysis Perspective, Is CDLX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Cardlytics Stock Split?

Cardlytics has split 0 times.

How Many Employees Does Cardlytics Have?

Cardlytics has 367 employees.

What is the current trading status of Cardlytics (CDLX)?

As of Jan 24, 2026, Cardlytics (CDLX) is trading at a price of 1.21, with a previous close of 1.20. The stock has fluctuated within a day range of 1.19 to 1.24, while its 52-week range spans from 0.85 to 4.03.

What Is Cardlytics (CDLX) Price Target According to Analysts?

The average 12-month price target for Cardlytics is USD1.63, with a high estimate of USD2 and a low estimate of USD1.5. 0 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +34.30% Upside potential.

What Is the CDLX After Hours Price?

CDLX's last after hours stock price is 1.18, the stock has decreased by -0.03, or -2.34%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.